Skip to main content
Erschienen in: Urolithiasis 6/2013

01.11.2013 | Original Paper

Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis

verfasst von: J. M. Baumann, B. Affolter, U. von Arx, M. Noël

Erschienen in: Urolithiasis | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

To get information on the consequences of adsorption of urinary macromolecules (UMs) on crystals, Ca phosphate (CaP) precipitation was performed in urine of 15 stone patients and 15 controls. In solutions of dissolved precipitates (DPU), Ca oxalate (CaOx) crystallization and aggregation (AGN) of latex beads were spectrophotometrically studied and compared to results obtained in urine and in UMs isolated by hemofilter dialysis (HD). Tests were repeated with a 20 μg/mL albumin solution (AS). Inhibition of CaOx growth and AGN was significantly reduced in DPU as well as in HD. Furthermore, DPU and HD showed an AGN of latex beads which in patients was more pronounced than in controls. Identical effects observed in DPU and HD can be explained by temporary high concentrations of UMs by adsorption on surfaces favoring self AGN. Temporary adsorption of AS on CaP produced polymers of a limited size, significantly reduced the inhibition of CaOx AGN and accelerated latex AGN. In DPU, AGN of latex beads occurred despite a surface potential of −37 mV, which within short distances produces areas of massive electrostatic repulsion and normally inhibits AGN. Such areas might be bridged by self-aggregated UMs. The retardation of CaOx AGN measured in DPU could be decisive whether during crystalluria crystals are washed out from the kidney by diuresis or are attached to kidney calcifications or pre-existing stones.
Literatur
1.
2.
Zurück zum Zitat Cook AF, Grover PK, Ryall RL (2009) Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int 103(6):826–835CrossRefPubMed Cook AF, Grover PK, Ryall RL (2009) Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int 103(6):826–835CrossRefPubMed
3.
Zurück zum Zitat Rodgers AL, Mensah PD, Schwager SL, Sturrock ED (2006) Inhibition of calcium oxalate cristallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences. Urol Res 34:373–380CrossRefPubMed Rodgers AL, Mensah PD, Schwager SL, Sturrock ED (2006) Inhibition of calcium oxalate cristallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences. Urol Res 34:373–380CrossRefPubMed
4.
Zurück zum Zitat Nakagawa Y (1997) Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion. Keio J Med 46(1):1–9CrossRefPubMed Nakagawa Y (1997) Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion. Keio J Med 46(1):1–9CrossRefPubMed
5.
Zurück zum Zitat Coe FL, Nakagawa Y, Asplin J, Parks JH (1994) Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab 20(6):378–384PubMed Coe FL, Nakagawa Y, Asplin J, Parks JH (1994) Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab 20(6):378–384PubMed
6.
Zurück zum Zitat Kolbach AM, Afzal O, Halligan B, Sorokina E, Kleinman JG, Wesson JA (2012) Relative deficiency of acidic isoforms of osteopontin from stone former urine. Urol Res 40(5):447–454CrossRefPubMed Kolbach AM, Afzal O, Halligan B, Sorokina E, Kleinman JG, Wesson JA (2012) Relative deficiency of acidic isoforms of osteopontin from stone former urine. Urol Res 40(5):447–454CrossRefPubMed
7.
Zurück zum Zitat Grohe B, Chan BP, Sørensen ES, Lajoie G, Goldberg HA, Hunter GK (2011) Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine. Urol Res 39(5):327–338CrossRefPubMed Grohe B, Chan BP, Sørensen ES, Lajoie G, Goldberg HA, Hunter GK (2011) Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine. Urol Res 39(5):327–338CrossRefPubMed
8.
Zurück zum Zitat Wang L, Guan X, Tang R, Hoyer JR, Wierzbicki A, De Yoreo JJ, Nancollas GH (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B 112(30):9151–9157CrossRefPubMed Wang L, Guan X, Tang R, Hoyer JR, Wierzbicki A, De Yoreo JJ, Nancollas GH (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B 112(30):9151–9157CrossRefPubMed
9.
Zurück zum Zitat Webber D, Rodgers AL, Sturrock ED (2007) Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Urol Res 35:277–285CrossRefPubMed Webber D, Rodgers AL, Sturrock ED (2007) Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Urol Res 35:277–285CrossRefPubMed
10.
Zurück zum Zitat Webber D, Radcliff CM, Royle L, Tobiasen G, Merry AH, Rodgers AL, Sturrock ED, Wormald MR, Harvey DJ, Dwek RA, Rudd PM (2006) Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. FEBS J 273(13):3024–3037CrossRefPubMed Webber D, Radcliff CM, Royle L, Tobiasen G, Merry AH, Rodgers AL, Sturrock ED, Wormald MR, Harvey DJ, Dwek RA, Rudd PM (2006) Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. FEBS J 273(13):3024–3037CrossRefPubMed
11.
Zurück zum Zitat Viswanathan P, Rimer JD, Kolbach AM, Ward MD, Kleinman JG, Wesson JA (2011) Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urol Res 39(4):269–282CrossRefPubMed Viswanathan P, Rimer JD, Kolbach AM, Ward MD, Kleinman JG, Wesson JA (2011) Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urol Res 39(4):269–282CrossRefPubMed
12.
Zurück zum Zitat Jaggi M, Nakagawa Y, Zipperle L, Hess B (2007) Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35:55–62CrossRefPubMed Jaggi M, Nakagawa Y, Zipperle L, Hess B (2007) Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35:55–62CrossRefPubMed
13.
Zurück zum Zitat Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength. J Urol 136:505–507PubMed Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength. J Urol 136:505–507PubMed
14.
Zurück zum Zitat Khan SR, Finlayson B, Hackett RL (1983) Stone matrix as proteins adsorbed on crystal surfaces: A microscopic study. Scan Electron Microsc 379–85 Khan SR, Finlayson B, Hackett RL (1983) Stone matrix as proteins adsorbed on crystal surfaces: A microscopic study. Scan Electron Microsc 379–85
15.
Zurück zum Zitat Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM (1999) Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Kidney Int 55:1776–1786CrossRefPubMed Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM (1999) Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Kidney Int 55:1776–1786CrossRefPubMed
16.
Zurück zum Zitat Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71–79CrossRefPubMed Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71–79CrossRefPubMed
17.
Zurück zum Zitat Baumann JM, Affolter B, Meyer R (2010) Crystal sedimentation and stone formation. Urol Res 38:21–27CrossRefPubMed Baumann JM, Affolter B, Meyer R (2010) Crystal sedimentation and stone formation. Urol Res 38:21–27CrossRefPubMed
18.
Zurück zum Zitat Saw NK, Rao PN, Kavanagh JP (2008) A nidus, crystalluria and aggregation: key ingredients for stone enlargement. Urol Res 36:11–15CrossRefPubMed Saw NK, Rao PN, Kavanagh JP (2008) A nidus, crystalluria and aggregation: key ingredients for stone enlargement. Urol Res 36:11–15CrossRefPubMed
19.
Zurück zum Zitat Edyvane KA, Hibberd CM, Harnett RM, Marshall VR, Ryall RL (1987) Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine. Clin Chim Acta 167(3):329–338CrossRefPubMed Edyvane KA, Hibberd CM, Harnett RM, Marshall VR, Ryall RL (1987) Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine. Clin Chim Acta 167(3):329–338CrossRefPubMed
20.
Zurück zum Zitat Wiggins RC (1987) Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions. Clin Chim Acta 162(3):329–340CrossRefPubMed Wiggins RC (1987) Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions. Clin Chim Acta 162(3):329–340CrossRefPubMed
21.
Zurück zum Zitat Baumann JM, Affolter B, Casella R (2011) Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls. Urol Res 39:421–427CrossRefPubMed Baumann JM, Affolter B, Casella R (2011) Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls. Urol Res 39:421–427CrossRefPubMed
22.
Zurück zum Zitat Baumann JM, Affolter B (2012) New pathological aspects of growth and prevention of kidney stones. Adv Urol (Epub 2012 May 20) Baumann JM, Affolter B (2012) New pathological aspects of growth and prevention of kidney stones. Adv Urol (Epub 2012 May 20)
23.
Zurück zum Zitat Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201–207CrossRefPubMed Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201–207CrossRefPubMed
24.
Zurück zum Zitat Baumann JM, Affolter B, Caprez U, Clivaz C, Glück Z, Weber R (2007) Stabilization of calcium oxalate suspension by urinary macromolecules, probably an efficient protection from stone formation. Urol Int 79:267–272CrossRefPubMed Baumann JM, Affolter B, Caprez U, Clivaz C, Glück Z, Weber R (2007) Stabilization of calcium oxalate suspension by urinary macromolecules, probably an efficient protection from stone formation. Urol Int 79:267–272CrossRefPubMed
25.
Zurück zum Zitat Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol (Renal Fluid Electrolyte Physiol 26) 257:F99–106 Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol (Renal Fluid Electrolyte Physiol 26) 257:F99–106
26.
Zurück zum Zitat Baumann JM, Affolter B, Caprez U, Clivaz C, von Arx U (2009) Role of calcium in the aggregation of particles coated by urinary macromolecules. Urol Int 82:459–463CrossRefPubMed Baumann JM, Affolter B, Caprez U, Clivaz C, von Arx U (2009) Role of calcium in the aggregation of particles coated by urinary macromolecules. Urol Int 82:459–463CrossRefPubMed
27.
Zurück zum Zitat Müller RH (1996) Zetapotential und Partikelladung in der Laborpraxis. Wissenschaftliche Verlagsgesellschaft, Stuttgart, p 37 Müller RH (1996) Zetapotential und Partikelladung in der Laborpraxis. Wissenschaftliche Verlagsgesellschaft, Stuttgart, p 37
28.
Zurück zum Zitat Kok DJ, Blomen LIMJ, Westbroek P, Bijvoet OLM (1986) Polysaccharide from coccoliths (CaCO3 Biomineral)—influence on crystallization of calcium oxalate monohydrate. Eur J Biochem 158:167–172CrossRefPubMed Kok DJ, Blomen LIMJ, Westbroek P, Bijvoet OLM (1986) Polysaccharide from coccoliths (CaCO3 Biomineral)—influence on crystallization of calcium oxalate monohydrate. Eur J Biochem 158:167–172CrossRefPubMed
29.
Zurück zum Zitat Hess B, Zipperle L, Jaeger P (1993) Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 265(6 Pt 2):F784–791 Hess B, Zipperle L, Jaeger P (1993) Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 265(6 Pt 2):F784–791
Metadaten
Titel
Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis
verfasst von
J. M. Baumann
B. Affolter
U. von Arx
M. Noël
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 6/2013
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0604-5

Weitere Artikel der Ausgabe 6/2013

Urolithiasis 6/2013 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.